Benserazide HCl

Catalog No.S2453 Synonyms: Ro-4-4602

For research use only.

Benserazide HCl (Ro-4-4602) is a peripherally-acting aromatic L-amino acid decarboxylase (AAAD) or DOPA decarboxylase inhibitor.

Benserazide HCl Chemical Structure

CAS No. 14919-77-8

Selleck's Benserazide HCl has been cited by 2 Publications

Purity & Quality Control

Choose Selective Decarboxylase Inhibitors

Biological Activity

Description Benserazide HCl (Ro-4-4602) is a peripherally-acting aromatic L-amino acid decarboxylase (AAAD) or DOPA decarboxylase inhibitor.
Targets
aromatic-L-amino-acid decarboxylase [1] DOPA decarboxylase [1]

Protocol (from reference)

Solubility (25°C)

In vitro

DMSO 58 mg/mL
(197.48 mM)
Water 58 mg/mL
(197.48 mM)
Ethanol 1 mg/mL warmed
(3.4 mM)

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 293.7
Formula

C10H15N3O5.HCl

CAS No. 14919-77-8
Storage 3 years -20°C powder
2 years -80°C in solvent
Smiles C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O.Cl

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Interventions Conditions Sponsor/Collaborators Start Date Phases
NCT01327261 Completed Drug: Levodopa + benserazide Healthy Volunteers University of Buenos Aires|Laboratorios Phoenix S.A.I.C.y F. August 2009 Phase 4
NCT00203164 Completed Drug: rasagiline mesylate Parkinson''s Disease Teva Branded Pharmaceutical Products R&D Inc. May 2002 Phase 3

(data from https://clinicaltrials.gov, updated on 2022-01-17)

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Benserazide HCl | Benserazide HCl supplier | purchase Benserazide HCl | Benserazide HCl cost | Benserazide HCl manufacturer | order Benserazide HCl | Benserazide HCl distributor